Activation_NN
of_IN
a_DT
novel_JJ
gene_NN
in_IN
3q21_NN
and_CC
identification_NN
of_IN
intergenic_JJ
fusion_NN
transcripts_NNS
with_IN
ecotropic_JJ
viral_JJ
insertion_NN
site_NN
I_NN
in_IN
leukemia_NN
._.

We_PRP
have_VBP
identified_VBN
a_DT
novel_JJ
gene_NN
,_,
GR6_NN
,_,
located_JJ
within_IN
the_DT
leukemia_NN
breakpoint_NN
region_NN
of_IN
3q21_NN
,_,
that_WDT
is_VBZ
normally_RB
expressed_VBN
in_IN
early_JJ
fetal_JJ
development_NN
but_CC
not_RB
in_IN
adult_JJ
peripheral_JJ
blood_NN
._.

GR6_NN
is_VBZ
activated_VBN
in_IN
the_DT
UCSD-AML1_NN
cell_NN
line_NN
and_CC
in_IN
a_DT
leukemic_JJ
sample_NN
,_,
both_DT
of_IN
which_WDT
carry_VBP
a_DT
t_NN
-LRB-_-LRB-
3_CD
;_:
3_CD
-RRB-_-RRB-
-LRB-_-LRB-
q21_NN
;_:
q26_NN
-RRB-_-RRB-
._.

In_IN
UCSD-AML1_NN
,_,
we_PRP
have_VBP
also_RB
identified_VBN
fusion_NN
transcripts_NNS
between_IN
the_DT
ecotropic_JJ
viral_JJ
insertion_NN
site_NN
I_CD
-LRB-_-LRB-
EVI1_NN
-RRB-_-RRB-
gene_NN
in_IN
3q26_NN
and_CC
GR6_NN
and_CC
between_IN
EVI1_NN
and_CC
Ribophorin_NN
I_NN
that_WDT
maps_VBZ
30_CD
kb_NN
telomeric_JJ
to_TO
GR6_NN
in_IN
3q21_NN
._.

All_DT
fusions_NNS
splice_VBP
the_DT
5_CD
'_POS
ends_NN
of_IN
the_DT
3q21_NN
genes_NNS
into_IN
exon_NN
2_CD
of_IN
the_DT
EVI1_NN
gene_NN
,_,
an_DT
event_NN
that_WDT
is_VBZ
similar_JJ
to_TO
the_DT
normal_JJ
intergenic_JJ
splicing_NN
of_IN
MDS1-EVI1_NN
and_CC
to_TO
those_DT
previously_RB
documented_VBN
in_IN
leukemias_NNS
with_IN
t_NN
-LRB-_-LRB-
3_CD
;_:
21_CD
-RRB-_-RRB-
and_CC
t_NN
-LRB-_-LRB-
3_CD
;_:
12_CD
-RRB-_-RRB-
,_,
in_IN
which_WDT
acute_JJ
myelogenous_JJ
leukemia_NN
1-EVI1_NN
fusions_NNS
and_CC
ETV6-EVI1_JJ
fusions_NNS
,_,
respectively_RB
,_,
occur_VBP
._.

The_DT
Ribophorin_NN
I-EVI1_NN
fusion_NN
in_IN
particular_JJ
may_MD
be_VB
a_DT
common_JJ
occurrence_NN
in_IN
t_NN
-LRB-_-LRB-
3_CD
;_:
3_CD
-RRB-_-RRB-
._.

